Drug intelligence / Profile preview

Guli capsule (Guizhou Bailing Group Pharmaceutical Co., Ltd.)

Development stage
Unknown
Lead developer
PegBio
Modality
Small Molecules
Administration
Oral
01

Overview

Guli capsule is a traditional Chinese medicine (TCM) developed by Guizhou Bailing Group Pharmaceutical Co Ltd for the treatment of various orthopedic and inflammatory joint conditions. It is primarily indicated for knee osteoarthritis, rheumatoid arthritis, and osteoporosis. The formulation has demonstrated the ability to suppress adjuvant-induced arthritis and reduce inflammatory swelling in preclinical studies. Clinically, it is utilized to alleviate joint pain and restore functional activity in patients. A Phase 4 clinical trial was conducted to evaluate its efficacy and safety in comparison to Kangguzengsheng capsules for knee osteoarthritis, focusing on its ability to improve symptoms and joint mobility.

Brand names
Guli
Other names
Guli capsuleGuli jiāonáng

Beyond the preview

Go deeper on Guli capsule (Guizhou Bailing Group Pharmaceutical Co., Ltd.).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guli capsule (Guizhou Bailing Group Pharmaceutical Co., Ltd.).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call